Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Carvedilol and adrenergic agonists suppress the lipopolysaccharide-induced NO production in RAW 264.7 macrophages via the adrenergic receptors

M. Pekarová, J. Králová, L. Kubala, M. Číž, I. Papežíková, T. Mačičková, J. Pečivová, R. Nosáľ, A. Lojek

. 2009 ; 60 (1) : 143-150.

Jazyk angličtina Země Polsko

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc11017154

The interaction of adrenergic agonists and/or antagonists with the adrenergic receptors expressed on immunologically active cells including macrophages plays an important role in regulation of inflammatory responses. Our study investigated the effects of carvedilol, a unique vasodilating beta-adrenergic antagonist, and endogenous adrenergic agonists (adrenalin, noradrenalin, and dopamine) and/or antagonists (prazosin, atenolol) on lipopolysaccharide-stimulated nitric oxide (NO) production from murine macrophage cell line RAW 264.7. The production of NO was determined as the concentration of nitrites in cell supernatants (Griess reaction) and inducible nitric oxide synthase (iNOS) protein expression (Western blot analysis). Scavenging properties against NO were measured electrochemically. Carvedilol in a concentration range of 1, 5, 10 and 25 microM inhibited iNOS protein expression and decreased the nitrite concentration in cell supernatants. Adrenalin, noradrenalin or dopamine also inhibited the iNOS protein expression and the nitrite accumulation. Prazosine and atenolol prevented the effect of both carvedilol and adrenergic agonists on nitrite accumulation and iNOS expression in lipopolysaccharide-stimulated cells. These results, together with the absence of scavenging properties of carvedilol against NO, imply that both carvedilol and adrenergic agonists suppress the lipopolysaccharide-evoked NO production by macrophages through the activation and modulation of signaling pathways connected with adrenergic receptors.

000      
03922naa 2200577 a 4500
001      
bmc11017154
003      
CZ-PrNML
005      
20121203110047.0
008      
110629s2009 pl e eng||
009      
AR
035    __
$a (PubMed)19439816
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Pekarová, Michaela, $d 1982-2019 $7 mub2011659519
245    10
$a Carvedilol and adrenergic agonists suppress the lipopolysaccharide-induced NO production in RAW 264.7 macrophages via the adrenergic receptors / $c M. Pekarová, J. Králová, L. Kubala, M. Číž, I. Papežíková, T. Mačičková, J. Pečivová, R. Nosáľ, A. Lojek
314    __
$a Institute of Biophysics of the AS CR, Kralovopolska, Kralovopolska 135, Brno, Czech Republic.
520    9_
$a The interaction of adrenergic agonists and/or antagonists with the adrenergic receptors expressed on immunologically active cells including macrophages plays an important role in regulation of inflammatory responses. Our study investigated the effects of carvedilol, a unique vasodilating beta-adrenergic antagonist, and endogenous adrenergic agonists (adrenalin, noradrenalin, and dopamine) and/or antagonists (prazosin, atenolol) on lipopolysaccharide-stimulated nitric oxide (NO) production from murine macrophage cell line RAW 264.7. The production of NO was determined as the concentration of nitrites in cell supernatants (Griess reaction) and inducible nitric oxide synthase (iNOS) protein expression (Western blot analysis). Scavenging properties against NO were measured electrochemically. Carvedilol in a concentration range of 1, 5, 10 and 25 microM inhibited iNOS protein expression and decreased the nitrite concentration in cell supernatants. Adrenalin, noradrenalin or dopamine also inhibited the iNOS protein expression and the nitrite accumulation. Prazosine and atenolol prevented the effect of both carvedilol and adrenergic agonists on nitrite accumulation and iNOS expression in lipopolysaccharide-stimulated cells. These results, together with the absence of scavenging properties of carvedilol against NO, imply that both carvedilol and adrenergic agonists suppress the lipopolysaccharide-evoked NO production by macrophages through the activation and modulation of signaling pathways connected with adrenergic receptors.
590    __
$a bohemika - dle Pubmed
650    _2
$a agonisté adrenergních receptorů $x farmakologie $7 D000322
650    _2
$a alfa blokátory $x farmakologie $7 D000317
650    _2
$a beta blokátory $x aplikace a dávkování $x farmakologie $7 D000319
650    _2
$a zvířata $7 D000818
650    _2
$a karbazoly $x aplikace a dávkování $x farmakologie $7 D002227
650    _2
$a buněčné linie $7 D002460
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a regulace genové exprese enzymů $x účinky léků $7 D015971
650    _2
$a lipopolysacharidy $7 D008070
650    _2
$a makrofágy $x metabolismus $x účinky léků $7 D008264
650    _2
$a myši $7 D051379
650    _2
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a synthasa oxidu dusnatého, typ II $x metabolismus $x účinky léků $7 D052247
650    _2
$a dusitany $x metabolismus $7 D009573
650    _2
$a propanolaminy $x aplikace a dávkování $7 D011412
650    _2
$a propanolaminy $x farmakologie $7 D011412
650    _2
$a adrenergní receptory $x metabolismus $x účinky léků $7 D011941
650    _2
$a signální transdukce $x účinky léků $7 D015398
655    _2
$a práce podpořená grantem $7 D013485
700    1#
$a Králová, Jana. $7 _AN059470
700    1_
$a Kubala, Lukáš, $d 1973- $7 xx0094314
700    1_
$a Číž, Milan. $7 jx20080610039
700    1_
$a Papežíková, Ivana $7 xx0098961
700    1_
$a Mačičková, Tatiana $7 xx0060743
700    1_
$a Pečivová, Jana $7 xx0112233
700    1_
$a Nosáľ, Radomír, $d 1941- $7 mzk2003196550
700    1_
$a Lojek, Antonín, $d 1954- $7 xx0063943
773    0_
$t Journal of Physiology & Pharmacology $g Roč. 60, č. 1 (2009), s. 143-150 $w MED00002908
910    __
$a ABA008 $b x $y 2
990    __
$a 20110720102337 $b ABA008
991    __
$a 20121203110118 $b ABA008
999    __
$a ok $b bmc $g 864183 $s 726951
BAS    __
$a 3
BMC    __
$a 2009 $b 60 $c 1 $d 143-150 $m Journal of physiology and pharmacology $n J Physiol Pharmacol $x MED00002908
LZP    __
$a 2011-3B09/BBjvme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé